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Abstract: Background: Equine asthma (EA) causes airflow impairment, which increases in severity with
exercise. Electrical impedance tomography (EIT) is an imaging technique that can detect airflow changes
in standing healthy horses during a histamine provocation test. Objectives: To explore EIT-calculated
flow variables before and after exercise in healthy horses and horses with mild-to-moderate (MEA) and
severe equine asthma (SEA). Animals: Nine healthy horses 9 horses diagnosed with MEA and 5 with
SEA were prospectively included. Methods: Recordings were performed before and after 15 minutes of
lunging. Absolute values from global and regional peak inspiratory (PIF, positive value) and expiratory
(PEF, negative value) flows were calculated. Data were analyzed using a mixed model analysis followed
by Bonferroni’s multiple comparisons test to evaluate the impact of exercise and diagnosis on flow indices.
Results: Control horses after exercise had significantly lower global PEF and PIF compared to horses
with SEA (mean difference [95% confidence interval, CI]: 0.0859 arbitrary units [AU; 0.0339-0.1379], P
< .001 and 0.0726 AU [0.0264-0.1188], P = .001, respectively) and horses with MEA (0.0561 AU [0.0129-
0.0994], P = .007 and 0.0587 AU [0.0202-0.0973], P = .002, respectively). No other significant differences
were detected. Conclusions and clinical importance: Electrical impedance tomography derived PIF and
PEF differed significantly between healthy horses and horses with SEA or MEA after exercise, but not
before exercise. Differences between MEA and SEA were not observed, but the study population was
small.
DOI: https://doi.org/10.1111/jvim.16260






The following work is licensed under a Creative Commons: Attribution-NonCommercial-NoDerivatives
4.0 International (CC BY-NC-ND 4.0) License.
Originally published at:
Herteman, Nicolas; Mosing, Martina; Waldmann, Andreas D; Gerber, Vinzenz; Schoster, Angelika (2021).
Exercise‐induced airflow changes in horses with asthma measured by electrical impedance tomography.
Journal of Veterinary Internal Medicine, 35(5):2500-2510.
DOI: https://doi.org/10.1111/jvim.16260
S T AND A RD A R T I C L E
Exercise-induced airflow changes in horses with asthma
measured by electrical impedance tomography
Nicolas Herteman1 | Martina Mosing2 | Andreas D. Waldmann3 |
Vinzenz Gerber4 | Angelika Schoster1
1Clinic for Equine Internal Medicine, Equine
Hospital, Vetsuisse Faculty, University of
Zurich, Switzerland
2School of Veterinary Medicine, College of
Science, Health, Engineering and Education,
Murdoch University, Perth, Australia
3Department of Anesthesiology and Intensive
Care Medicine, Rostock University Medical
Center, Rostock, Germany
4Equine Clinic, Swiss Institute of Equine
Medicine, University of Bern and Agroscope,
Berne, Switzerland
Correspondence
Nicolas Herteman, Faculty of Veterinary
Medicine—Center of Clinical Sciences-Equine
Medicine and Reproduction, Ludwig-
Maximilians University, Munich, Germany.
Email: nherteman.dacvimla@gmail.com
Present address
Nicolas Herteman, Faculty of Veterinary
Medicine—Center of Clinical Sciences-Equine
Medicine and Reproduction, Ludwig-
Maximilians University, Munich, Germany
Funding information
Stiftung Symphasis; Fond Karin Grote
Abstract
Background: Equine asthma (EA) causes airflow impairment, which increases in
severity with exercise. Electrical impedance tomography (EIT) is an imaging technique
that can detect airflow changes in standing healthy horses during a histamine
provocation test.
Objectives: To explore EIT-calculated flow variables before and after exercise in
healthy horses and horses with mild-to-moderate (MEA) and severe equine
asthma (SEA).
Animals: Nine healthy horses 9 horses diagnosed with MEA and 5 with SEA were
prospectively included.
Methods: Recordings were performed before and after 15 minutes of lunging.
Absolute values from global and regional peak inspiratory (PIF, positive value) and
expiratory (PEF, negative value) flows were calculated. Data were analyzed using a
mixed model analysis followed by Bonferroni's multiple comparisons test to evaluate
the impact of exercise and diagnosis on flow indices.
Results: Control horses after exercise had significantly lower global PEF and PIF com-
pared to horses with SEA (mean difference [95% confidence interval, CI]: 0.0859
arbitrary units [AU; 0.0339-0.1379], P < .001 and 0.0726 AU [0.0264-0.1188],
P = .001, respectively) and horses with MEA (0.0561 AU [0.0129-0.0994], P = .007
and 0.0587 AU [0.0202-0.0973], P = .002, respectively). No other significant differ-
ences were detected.
Conclusions and Clinical Importance: Electrical impedance tomography derived PIF
and PEF differed significantly between healthy horses and horses with SEA or MEA
after exercise, but not before exercise. Differences between MEA and SEA were not
observed, but the study population was small.
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1 | INTRODUCTION
Equine asthma (EA) is a unifying description for chronic noninfectious
inflammatory lower airway diseases in horses.1-3 It has been recog-
nized previously as the second most common cause of poor perfor-
mance in racing Thoroughbreds.4 Inflammation leads to
bronchoconstriction, mucus accumulation and impairment of gas
exchange.1,5-9 Horses with the uncontrolled severe form of equine
asthma (SEA) show increased respiratory effort at rest because of
these impairments of gas exchange. However, if asthma is controlled,
clinical signs might not be present at rest and lung function impair-
ments might only be seen with exercise. In asthmatic horses, most air-
way narrowing occurs only in the most distal airways, accounting for
only a small part of the total airway resistance. Thus, milder degrees
of airway narrowing go undetected at rest using most currently avail-
able tools.10,11 It has been shown however that impairment of gas
exchange occurs in horses with MEA.10,11 Lung function impairment
might not be detectable at rest but could become evident during or
after exercise in horses with MEA.
To confirm clinical suspicion of EA in the field, several diagnostic
modalities, such as owner questionnaires, arterial oxygen tension, tra-
cheal endoscopy, bronchoalveolar lavage fluid (BALF) cytology or a
combination thereof, are used.1 Although these diagnostic tests can
establish a diagnosis of EA, and in conjunction with clinical signs can
differentiate between SEA and MEA, none of these tests can evaluate
lung function in the field.12 A method by which practitioners can eas-
ily evaluate lung function in the field would be a valuable addition.
Electrical impedance tomography (EIT) is a noninvasive, radiation-
free, real-time imaging technique that assesses gas volume shifts in
the lungs based on measurement of impedance changes by placing an
electrode belt around the thorax.13 Small alternating high frequency
and low amplitude electrical currents are applied through a pair of the
electrodes, while the resulting surface potentials are measured by the
remaining electrodes.14 Based on this relationship between imped-
ance change and gas volume, EIT measurements allow evaluation of
global and regional lung volume during inspiration and expiration. The
impedance change of all pixels within the EIT image can be used as a
surrogate of tidal volume (VTΔZ). From the assumption that the
impedance change represents a volume signal, peak inspiratory (PIF)
and peak expiratory (PEF) global flow can be evaluated by calculating
the first derivative of the global EIT volume signal.15 All EIT variables
including these flow indices are expressed in arbitrary units (AU).
Electrical impedance tomography has been used in equine
medicine to monitor distribution of ventilation under general
anesthesia,16-18 and in standing horses.19 A recent study showed that
EIT can detect airflow changes caused by bronchoconstriction in
healthy sedated horses during a histamine provocation test based on
changes in flow variables.15 The effect of exercise on EIT-calculated
variables that represent exercise-induced airflow changes in healthy
horses or horses with EA has not yet been described.
Our objective was to explore differences in pre- and postexercise
indices of EIT-derived airflow indices between healthy horses and
horses with EA. The hypothesis was that EIT flow variables would
increase after exercise and a difference could be detected between
healthy horses and horses with EA.
2 | MATERIAL AND METHODS
This study had ethical and institutional approval (ZH 166/15). All
owners signed an informed consent form.
2.1 | Animals
Horses were enrolled from the teaching horse herd of the University of
Bern (n = 5), the Swiss National Horse Center (n = 6), horses owned by
staff members of the University of Zurich (n = 2) and the patient popula-
tion of the University of Zurich between May 2017 and 2019 (n = 14;
Table 1). Inclusion criteria for the control horses (Figure 1) were: no his-
tory or physical examination findings of respiratory disease (ie, cough,
respiratory rate >16 breaths per minute [bpm], nostril flaring or increased
abdominal effort) or exercise intolerance, and a BALF neutrophil propor-
tion <10%, mast cell proportion <2%, and eosinophil proportion ≤1%.
Inclusion criteria for horses with EA were a history or physical examina-
tion findings of respiratory disease (cough, respiratory rate >16 bpm, nos-
tril flaring or increased abdominal effort) or exercise intolerance and an
increased percentage of at least 1 type of granulocyte (neutrophil propor-
tion ≥10%, mast cell proportion ≥2%, or eosinophil proportion >1%) on
evaluation of BALF cytology. Differentiation into MEA and SEA was
based on clinical signs of respiratory disease at rest (respiratory rate
>16 bpm, nostril flaring or increased abdominal effort), “horse owner
assessed respiratory signs index” (HOARSI), PaO2 and tracheal mucus
score (Figure 1) and confirmed by BALF cytology (neutrophil proportion
>20%). Exclusion criteria for horses from both groups were a history of
exercise-induced pulmonary hemorrhage (EIPH) or treatment with corti-
costeroids or bronchodilators within 2 weeks before presentation.
2.2 | Owner questionnaire
All owners were asked to complete the HOARSI, which is a validated
standardized questionnaire based on clinical signs (cough frequency,
nasal discharge, breathing at rest, and during work).20,21 A HOARSI of
3 was considered suggestive for horses with moderate to severe signs
(MEA or SEA), and a HOARSI of 4 for horses with severe clinical
signs of respiratory disease, compatible with SEA. This questionnaire
was used in conjunction with the other variables to classify horses
with EA as MEA or SEA (Figure 1).
2.3 | Clinical respiratory tract examination,
including EIT measurements
The respiratory tract examination of the horses consisted of a general
clinical examination including rebreathing bag examination. An arterial
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F IGURE 1 Flow chart for classification of study horses into controls, and MEA- and SEA-affected horses. BALF, bronchoalveolar lavage fluid;
MEA, mild-to-moderate equine asthma; SEA, severe equine asthma
TABLE 1 Population characteristics
of the groups
Controls (n = 9) MEA (n = 9) SEA (n = 5)
Median Range Median Range Median Range
Age (years) 12 (10-15) 12 (10-27) 16 (9-21)
Weight (kg) 540 (500-575) 525 (385-565) 500 (375-580)
HOARSI score 1 (1) 2.5 (1-3) 4 (4)
PaO2 at rest (mm Hg) 97 (93-98) 89.5 (80-97.1) 76.9 (68.1-79.7)
Mucus score 1 (0-1) 2 (1-4.5) 2.5 (2, 3)
BALF cytology
Neutrophils (%) 5 (2.5-9) 9 (0-13.5) 28.5 (23.5-35)
Mast cells (%) 1 (0-1.5) 3 (0-11.5) 1 (0-4)
Eosinophils (%) 0 0 0 (0-6) 0 (0-0)
Lymphocytes (%) 50 (33.5-66) 45 (24.5-72) 44 (38-59)
Macrophages (%) 46 (27.5-60) 47 (18-67) 31 (16.5-32)
Note: Numerical values are reported as median and range.
Abbreviations: BALF, bronchoalveolar lavage fluid (differential cell count performed on 200 cells);
HOARSI, horse owner assessed respiratory signs index; MEA, mild-to-moderate equine asthma; PaO2,
arterial oxygen tension; SEA, severe equine asthma.
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blood sample then was obtained from the carotid artery using an 18 g
needle and drawn into a 1 mL heparinized syringe. The arterial blood
sample was immediately analyzed using a blood gas analyzer
(RAPIDPoint 500, Siemens Healthcare). The arterial oxygen pressure
(PaO2) at rest was considered decreased when paO2 was <80 mm Hg
(Equine hospital Zurich: 526 m over sea level). The EIT measurements
then were made using an EIT device running software recording EIT
raw impedance data (BBVet, SenTec, Landquart, Switzerland) before
and after 15 minutes of lunging (5 minutes at a walk, 5 minutes at a
trot, and 5 minutes at canter). For EIT data collection, an electrode
belt (elastic rubber belt with 32 stainless steel electrodes equidistantly
mounted) was placed around the thorax in a transverse plane,
between the 5th and 6th intercostal space. The coat of the horses
was not clipped but moistened by application of water and gel to max-
imize skin contact with the electrodes and optimize conduction of cur-
rent. A mark was made in the haircoat using a clipper when the belt
was in the desired location, to allow for repeated positioning of the
belt in the same location after exercise. Ten to 12 consecutive respira-
tion cycles of good quality without movement artifacts were recorded
while the horse was standing quietly. Thereafter, the belt was taken
off and the horse was lunged for 15 minutes. After lunging, the EIT
belt was placed in the same position as for baseline measurements
and recording was performed in the same manner as before exercise.
To avoid detecting airflow changes associated with differing respira-
tory rates, recording was started when the respiratory rate had
reached the equivalent of the resting respiratory rate. The respiratory
rate was determined by visual assessment of flank movement and
counted over 1 minute. After EIT recording, the belt was taken off for
the remainder of the examination.
Horses then were sedated using detomidine (20-40 μg/kg, IV;
Domosedan ad us. vet., Provet AG, Lyssach b. Burgdorf, CH) and
butorphanol (10-20 μg/kg, IV; Alvegesic 1% forte ad us. vet., Virbac
Switzerland AG, Glattbrugg, CH) for endoscopic evaluation of the
respiratory tract using a 1.8-m long endoscope (Karl Storz GmBH,
Tuttlingen, Germany) passed through the nasal passage into the
trachea. Pictures were recorded and accumulation of mucus was
graded by the attending veterinarian as previously described.22
Bronchoalveolar lavage then was performed using a standard protocol
with a bronchoalveolar lavage (BAL) catheter (large animal BAL cathe-
ter; Mila International Inc, Florence, Kentucky) that was passed through
the nose into the bronchus until it was wedged. While passing the
catheter, 20 mL lidocaine 2% (Lidocaine 2%; Streuli Pharma AG,
Switzerland) mixed with 30 mL sterile saline (0.9% NaCl, 1000 mL,
Laboratorium Dr G. Bichsel, Interlaken) was injected through the cathe-
ter to decrease the cough reflex. After the catheter was wedged, a
BAL was performed by instilling 250 mL of sterile saline (0.9% NaCl,
1000 mL, Laboratorium Dr G. Bichsel, Interlaken, Switzerland), in
5 boluses of 50 mL each. After the boluses, the fluid was reaspirated
by gentle suction using the same syringe until no additional fluid was
obtained. Cytopreparations from unfiltered BALF were stained with
Wright-Giemsa. Differential counts of 200 inflammatory cells were
performed by a board-certified clinical pathologist at the Veterinary
Medical Laboratory of the University of Zurich.
2.4 | Blood sampling for hematology and
biochemistry analysis
Blood was collected by venipuncture from the jugular vein into potas-
sium ethylenediaminetetraacetic acid (Vacuette, K3EDTA, 4 mL, Greiner
bio-one, St Gallen, Switzerland), lithium heparin (Vacuette, Lithium Hep-
arin, 6 mL, Greiner bio-one) and sodium citrated tubes (Vacuette, Coag-
ulation sodium citrate 3.2%, 2 mL, Greiner bio-one) tubes. Complete
blood count (Sysmex XT 2000iV, Sysmex Cooperation, Kobe, Japan;
multispecies automated hematology analyzer, validated for equine sam-
ples), serum biochemistry (Cobas 6000 <501> System, Roche Diagnos-
tics, Rotkreuz, Switzerland), including serum amyloid A protein (SAA;
automated turbidimetric immunoassay, LZ Test Eiken SAA; on Cobas
501 system; Roche Diagnostics) and fibrinogen Clauss (STart Max,
DIAGNOSTICA STAGO, France) assays were performed by the Veteri-
nary Medical Laboratory of the University of Zurich within 1 hour after
sampling.
2.5 | EIT analysis
Ten to 12 stable consecutive breaths were analyzed by exporting the
recorded EIT raw impedance data to Matlab (Mathworks). Based on a mod-
ified Granz consensus reconstruction algorithm for EIT (GREIT)23 that was
adapted for horse anatomy, individual images of impedance changes were
generated. The regions of interest (ROI) representing the lung area were
first divided into halfs and the impedance change (ΔZ) evaluated for each
region: ventral (ΔZVent) vs dorsal (ΔZDors) and left (ΔZLeft) vs right (ΔZRight).
The EIT tidal volume-related factor (VTΔZ expressed in AU) was cal-
culated. Based on this calculation, the global peak expiratory (PEFGlobal)
and inspiratory (PIFGlobal) flows were calculated (expressed in AU) from
all pixels within the total ROI area for each breath. The peak flows then
were evaluated for each half and further reported as left, right, ventral,
and dorsal peak expiratory flows (PEFLeft, PEFRight, PEFVent, and PEFDors,
respectively) and the corresponding inspiratory flows (PIFLeft, PIFRight,
PIFVent, and PIFDors). Based on the direction of ΔZ, inspiratory values
were defined as positive, whereas expiratory values were negative.
Absolute values of PEF and PIF were considered for statistical analyses.
The shift in distribution of the gas in the lungs measured by EIT is
expressed as a single variable known as “center of ventilation” (CoV).
Its position is expressed as a percentage of the ventro-dorsal extension
of the lung region, with 0% referring to the most ventral part of the
lung and 100% to the most dorsal part (CoVVD). The position of the
CoV between the right and left lung can be further defined as a per-
centage (0% referring to the most lateral part of the right lung and
100% to the most lateral part of the left lung, CoVRL). The CoVVD and
CoVRL were calculated for each horse before and after exercise.
2.6 | Data analysis
Normality of the data was assessed using the Kolmogorov-Smirnov
test. To evaluate the effects of exercise and disease on global PEF
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and PIF, as well as all regional PEF and PIF results, a repeated-
measures mixed-effect model analysis (restricted maximum likelihood
approach) was used. The fixed factors included “diagnosis” (control,
MEA, and SEA), “exercise” (before and after lunging) and the interac-
tion “diagnosis*exercise.” “Horse” was considered a random variable.
If a significant effect of interaction was identified, a Bonferroni post
hoc test was performed for multiple comparisons.
Analyses were performed using Prism 8.03.1 (GraphPad Software,
Inc, California), and P < .05 was considered significant. Normally dis-




Based on classification criteria, 9 healthy controls and 14 horses with EA
(9 MEA and 5 SEA, Figure 1) were included in the study. The healthy con-
trol group consisted only of Warmbloods; 2 were female and 7 were
geldings. The asthma group consisted of 3 Quarter Horses and associated
breeds, 4 Warmbloods, 1 Irish Cob, 1 Canadian, 2 Icelandic, 1 Connemara,
1 Andalusian, and 1 Haflinger. There were 4 females, 9 geldings, and
1 stallion.
History and clinical signs of all horses are shown in Supporting
Information S1.
Four of the controls and 1 of the horses with EA could not be
exercised because of lameness, resulting in 4 controls and 13 EA
horses with complete data sets (Supporting Information S1). One
client-owned horse in the SEA group did not have results from BALF
cytology available because the sample was nondiagnostic.
3.2 | EIT-based expiratory flow variables
Indices of global expiratory flow (PEFGlobal) are shown in Figure 2A.
There was a significant interaction effect of diagnosis and exercise on
PEFGlobal (P = .01). Compared to healthy horses, PEFGlobal was signifi-
cantly higher in horses with MEA (mean difference [95% CI]:
0.0561 AU [0.0129-0.0994], P = .01) and in horses with SEA (mean
difference [95% CI]: 0.0859 AU [0.0339-0.1379], P < .001) after exer-
cise. There was no difference between SEA and MEA (mean differ-
ence [95% CI]: 0.0298 AU [0.0169 to 0.0765], P = .35) after
exercise or in any comparisons before exercise (all P > .99). In contrast
to healthy horses, PEFGlobal increased significantly after exercise in
horses with MEA and SEA (mean difference [95% CI]: 0.0445 AU
[0.0086-0.0805], P = .013 and 0.0729 AU [0.0213-0.1245], P = .005,
respectively).
Regional PEF variables are shown in Figure 3. There was a signifi-
cant interaction effect between diagnosis and exercise for PEFLeft
(P = .03), PEFRight (P = .04) and PEFVentral (P = .004), but not in
PEFDorsal (P = .07). Compared to healthy horses, PEFLeft and PEFRight
were significantly higher in horses with MEA (mean difference [95%
CI]: 0.0326 AU [0.0017-0.0634], P = .04 and 0.0327 AU [0.0051-
0.0603], P = .02, respectively) and in horses with SEA (mean differ-
ence [95% CI]: 0.0439 AU [0.0068-0.0809], P = .02 and 0.0401 AU
[0.0069-0.0732], P = .01, respectively) after exercise. Compared to
controls, PEFVentral was significantly higher in horses with SEA (mean
difference [95% CI]: 0.0675 AU [0.0245-0.1105], P = .001), but not in
horses with MEA (mean difference [95% CI]: 0.0352 AU [0.0007 to
0.0711], P = .06) after exercise. There was no difference between
MEA and SEA after exercise (mean difference [95% CI]: 0.0323 AU
[0.0071 to 0.0717], P = .14) and no differences between any groups
before exercise (all P > .999). In contrast to healthy horses, PEFVentral
F IGURE 2 Global peak expiratory and inspiratory flow in healthy horses and horses with mild-moderate equine asthma (MEA) and severe
equine asthma (SEA), before and after exercise. Values of global peak expiratory flow (PEFGlobal; A) and inspiratory flow (PIFGlobal; B) in controls
and asthmatic horses, before and after exercise. Each symbol denotes a single animal, and points from the same animal with were connected with
lines. The P-values, when significant, are indicated in the figure
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F IGURE 3 Regional peak expiratory flows in healthy horses and horses with mild-moderate equine asthma (MEA) and severe equine asthma
(SEA), before and after exercise. Values of ventral (PEFVentral, A), dorsal (PEFDorsal, B), left (PEFLeft, C), and right (PEFRight, D) expiratory peak flows
in controls and asthmatic horses, before and after exercise. Each symbol denotes a single animal, and points from the same animal with were
connected with lines. The P-values, when significant, are indicated in the figure
F IGURE 4 Regional inspiratory flows in healthy horses and horses with mild-moderate equine asthma (MEA) and severe equine asthma (SEA),
before and after exercise. Values of ventral (PIFVentral, A), dorsal (PIFDorsal, B), left (PIFLeft, C), and right (PIFRight, D) inspiratory peak flows in
controls and asthmatic horses, before and after exercise. Each symbol denotes a single animal, and points from the same animal with were
connected with lines. The P-values, when significant, are indicated in the figure
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and PEFLeft significantly increased after exercise in horses with MEA
and SEA (mean difference [95% CI] of PEFVentral: 0.0243 AU [0.0004-
0.0481], P = .04 and 0.0482 AU [0.0133-0.0830], P = .006, respec-
tively; PEFLeft: 0.0266 AU [0.0033-0.0499], P = .02 and 0.0363 AU
[0.0025-0.07], P = .03, respectively). In horses with SEA, PEFRight sig-
nificantly increased after exercise (mean difference [95% CI]:
0.0307 AU [0.001-0.0604], P = .04), but not in horses with MEA
(mean difference [95% CI]: 0.0188 AU [0.0017 to 0.0392], P = .08).
3.3 | EIT-based inspiratory flow variables
Indices of global inspiratory flow are shown in Figure 2B. There was a
significant interaction effect of diagnosis and exercise on PIFGlobal
(P = .002). Compared to healthy controls, PIFGlobal was significantly
higher after exercise in horses with MEA (mean difference [95% CI]:
0.0587 AU [0.0202-0.0973], P = .002) and in horses with SEA (mean
difference [95% CI]: 0.0726 AU [0.0264-0.1188], P = .001). There
was no difference between SEA and MEA (mean difference [95% CI]:
0.0139 AU [0.0564 to 0.0286], P > 0.99) after exercise or in any
comparisons before exercise (all P > 0.5). In horses with SEA, PIFGlobal
significantly increased after exercise (mean difference [95% CI]:
0.0528 AU [0.0168-0.0888], P = .004).
Regional PIF variables are shown in Figure 4. There was a signifi-
cant interaction effect between diagnosis and exercise for all regional
PIF (mean difference [95% CI] of PIFVentral: P = .002, PIFDorsal: P = .01,
PIFLeft: P = .02, and PIFRight: P < .001). Compared to healthy controls,
PIFDorsal was significantly higher in horses with MEA (mean difference
[95% CI]: 0.0303 AU [0.0092-0.0514], P = .003), but not in horses with
SEA (mean difference [95% CI]: 0.0155 AU [0.0408 to 0.0098],
P = .4) after exercise. Compared to healthy controls, PIFVentral, PIFLeft
and PIFRight were significantly higher in horses with MEA (mean
difference [95% CI]: 0.0322 AU [0.0063-0.0582], P = .01; 0.0297 AU
[0.0081-0.0512], P = .004; and 0.0409 AU [0.0136-0.0682], P = .002,
respectively) and horses with SEA (mean difference [95% CI]:
0.0545 AU [0.0234-0.0856], P < .001; 0.0310 AU [0.0052-0.0569],
P = .01; and 0.0441 AU [0.0114-0.0767], P = .005, respectively). After
exercise, none of the EIT-calculated inspiratory variables were signifi-
cantly different between horses with MEA and horses with SEA (all
P > .35). Before exercise, there was no difference between any groups
(all P > .9). In horses with SEA, PIFVentral and PIFRight were significantly
increased after exercise (mean difference [95% CI]: 0.0528 AU
[0.0168-0.0888], P = .004 and 0.0269 AU [0.0058-0.0481], P = .01,
respectively). In horses with MEA, PIFDorsal was significantly increased
after exercise (mean difference [95% CI]: 0.0156 AU [0.0015-0.0296],
P = .03). In healthy horses, PIFRight was significantly decreased after
exercise (mean difference [95% CI]: 0.0247 AU [0.0061-
0.0432], P = .008).
3.4 | Center of ventilation and VTEIT
There was no significant effect of the interaction “exercise*diagnosis”
on VTΔZ (P = .13) or on the position of the CoVRL (P = .67) or CoVVD
(P = .78) in this population. Data are shown in Table 2.
4 | DISCUSSION
Results from our study show that EIT flow variables can detect differ-
ences in lung function between healthy horses and horses with
asthma after exercise. No differences at rest were seen between the
2 study groups. No significant difference was found for flow variables
between MEA and SEA horses after exercise.
TABLE 2 Center of ventilation and
tidal volume measured by electrical
impedance tomography for all horses in
each group (before and after exercise)
Other parameters
Horses CoV ventral to dorsal (%) CoV right to left (%) VTΔZ
Controls—Before exercise (n = 9) 57.81 53.53 3.32
±SD ±5.98 ±6.06 ±0.80
Controls—After exercise (n = 5) 60.62 52.13 3.12
±SD ±2.13 ±3.17 ±1.24
MEA—Before exercise (n = 10) 52.44 49.83 4.31
±SD ±8.52 ±4.85 ±1.14
MEA—After exercise (n = 10) 51.69 49.37 4.19
±SD ±5.42 ±7.34 ±1.16
SEA—Before exercise (n = 6) 60.25 49.31 2.59
±SD ±9.42 ±7.24 ±0.63
SEA—After exercise (n = 5) 63.07 49.97 3.03
±SD ±8.97 ±4.13 ±0.67
Note: Numerical values are reported as mean ± SD or median (range). Significance was set at P < .05.
Abbreviations: CoV (%), center of ventilation; MEA, mild-to-moderate equine asthma; SEA, severe equine
asthma; VTΔZ, estimate of tidal volume from electrical impedance tomography.
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4.1 | EIT utilization in horses without sedation and
directly after exercise
Pulmonary function tests are important, routinely-used tools in the
diagnosis of obstructive or restrictive lung disease in human medi-
cine.12,24 Their application in equine medicine is largely limited to
referral centers because of the need for specialized equipment such
as facemasks, high-speed treadmills for horses, and esophageal
manometers. Sedation often is required, which impacts pulmonary
function and complicates interpretation of results.25,26 We investi-
gated the use of EIT, a noninvasive imaging technique based on elec-
trical impedance in horses with EA. Measurements were easily
performed in all horses without sedation and required a minimal
amount of time for data collection. The EIT measurements could be
repeated shortly after exercising the horse, without any impairment
by behavior or adverse effects.
4.2 | Bronchoconstriction and EA
Regardless of the severity of EA, PEFGlobal was significantly increased
as compared to healthy horses after exercise and significantly higher
within each asthma group after exercise compared to before exercise.
During inspiration, a significant difference in PIFGlobal was seen in
asthmatic horses as compared to healthy horses after exercise. How-
ever, an increase in PIFGlobal was seen only in SEA-affected horses,
and not in MEA-affected horses, when comparing before and after
exercise. The increase in global flow indices after exercise in severely
asthmatic horses was more pronounced during expiration with an
increase of 94% compared to inspiration during which an increase of
83% was observed. For MEA, the increase was similar for both flows
(60% for expiration and 66% for inspiration). These findings are
expected because EA is a lower airway disease, and affects expiration
to a greater extent than inspiration.27 The fact that only SEA horses
had increased postexercise PIFGlobal may be attributed to more severe
airway narrowing or may be a consequence of the small number of
horses in the study. Recent studies showed that EIT can detect airflow
changes in standing sedated adult healthy horses during a histamine
provocation test and after the administration of salbutamol.15,28 In
these studies, EIT flow calculations correlated well with plethysmogra-
phy measurements (including flow-volume loops), which is a validated
method to measure different degrees of airway narrowing or dilata-
tion.15,28 The same EIT algorithm was used in our study to calculate
peak inspiratory and expiratory flow changes, based on impedance
variations measured by the EIT. No changes in VTΔZ, represented by
the total impedance change of all pixels over a breathing cycle, were
seen between any group of horses or time points. This observation is
important to note because flow changes can only be attributed to
changes in airway diameter at constant tidal volumes (Poiseuille's law).
This confirms that the changes seen in PEF and PIF are a consequence
of exercise-induced airway narrowing instead of changes in tidal vol-
ume as could be argued. Differences between healthy horses and
horses with SEA at rest also would be expected because horses with
SEA have clinical signs of bronchoconstriction at rest. The absence of
this difference in our study is likely a result of low power, with only
5 horses in the SEA group.
The distribution of ventilation represented by the CoV in our
study was not different between healthy horses and horses affected
by MEA or SEA, neither before nor after exercise. Changes in the dis-
tribution of ventilation were reported to be heterogeneous in humans
suffering from asthma,29 with the phenomenon of air trapping in
severe asthma occurring mostly in the lower pulmonary lobes.30 This
finding indicates that CoV might not be the best variable to use for
EIT-based lung function evaluation in asthmatic horses.
4.3 | Regional flows and distribution of ventilation
One advantage of EIT compared to other lung function tests is that it
also allows regional assessment of airflow. The EIT was able to detect
more difference in the ventral area of the lungs after exercise as
compared to the dorsal area. During expiration, a significant effect of
exercise was identified in both asthmatic groups, whereas only
SEA-affected horses had increased inspiratory ventral flow. This find-
ing is in agreement with the aforementioned fact that asthma affects
expiration more than inspiration.27 To our knowledge, no data indicate
that the ventral area of the lungs may be more affected by asthma in
humans or any animal species. This observation however may be
explained by the anatomy of the equine lungs. Both lungs have a
similar shape with a ventral cardiac notch that separates a smaller cra-
nial portion from a larger caudal lung portion.31 In the standing horse,
most of the lung is dorsal to the diaphragm31; therefore, the pulmo-
nary volume is smaller ventrally than dorsally. The CoVVD in our study
also was located slightly dorsal in healthy horses, supporting the
smaller ventral pulmonary volume. It could be hypothesized that
the smaller ventral pulmonary volume may facilitate detection of mild
to severe airflow changes in that area. A previous study reported that
the CoVVD in healthy horses was located ventrally.
19 This discrepancy
may be associated with a difference in the definition of the CoV. The
previously mentioned study evaluated CoVVD position based on
thoracic height and not based on the ROI of the lungs as done in
our study.
A postexercise increase in airflow in the left and right lungs was
noticed in both asthmatic groups in comparison to healthy horses.
During expiration, more changes were noticed in the left lung in com-
parison to the right lung.
Similar to prior studies, the position of the CoVRL at rest was
located slightly more to the right in healthy horses and in horses with
EMA and SEA.15,19 This finding might be attributed to equine pulmo-
nary anatomy, as the right lung is larger because of the presence of
the accessory lobe.31 The CoVRL was not significantly different
between healthy horses and horses with EA, suggesting that air is not
redistributed in EA. The presence of airflow changes in both lungs in
horses with EA after exercise supports the fact that both lung halves
are affected equally. This observation is in agreement with the
systemic component of EA.32-34 Additional studies with higher case
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numbers are needed to evaluate whether these variables or a combi-
nation of them are useful for the diagnosis of EA and differentiating
between MEA and SEA.
4.4 | EIT calculation and future approach to lung
function testing
Mild-to-moderate EA is known to decrease performance in
racehorses,35 but only causes subtle respiratory clinical signs at rest.1
These features make it difficult to diagnose MEA without additional
diagnostic testing. Airway hyperreactivity is recognized as the cause
of exercise-induced bronchoconstriction.10,11 This necessitates a
dynamic diagnostic measurement immediately after exercise, such
as forced expiratory volume over 1 second, which is used in human
medicine.36 In equine medicine, other lung function tests are
used such as oscillometry,37 plethysmography combined with
bronchoprovocative challenge38,39 and forced expiratory
maneuvers,40 but these diagnostic tests are not practical for use in
the field. Electrical impedance tomography measurements can be
obtained in the field, but none of the flow variables used in our study
showed a significant difference between MEA and SEA. On the other
hand, our study was not specifically designed to distinguish between
MEA and SEA, but to explore a difference between healthy and EA-
affected horses before and after exercise. Therefore, additional stud-
ies with larger numbers of horses will be needed to assess whether a
difference in regional or global PEF or PIF could distinguish between
horses with MEA and SEA.
Another future approach would be to use other algorithms in
addition to expiratory and inspiratory flow to evaluate EIT measure-
ments. The EIT-derived flow-volume loops may prove useful in
naturally-occurring EA because it has been shown recently that
indices derived from the shape of flow-volume loops change after
histamine bronchoprovocation in healthy horses.28 This study
compared EIT changes to plethysmography and found a similar pro-
gression of all variables during histamine challenge and subsequent
bronchodilatation using albuterol. Flow-volume loops should be evalu-
ated in horses with EA in the future to determine if these variables
could distinguish between MEA and SEA.
Contrary to our hypothesis, no difference was found between
healthy and SEA-affected horses at rest. This may be explained by the
fact that the severely asthmatic horses were not in acute crisis during
examination, and the remodeling of the airways might not have been
pronounced enough to induce detectable airflow changes at rest.
However, the study population was small, and therefore additional
studies would be beneficial.
4.5 | Limitations
The main limitation of our study was the small number of horses in
each group, which was the case for several reasons. We elected to
exclude horses that had been treated with corticosteroids or
bronchodilators 2 weeks before presentation, which is the case for
many of our patients. We also elected to use stringent criteria includ-
ing both clinical signs and BALF findings. Several controls could not
be exercised and therefore only data at rest were available. However,
even with the relatively low numbers of horses in both groups, we
found significant differences in our main outcome variables. We antic-
ipated low numbers of healthy controls from our patient population
and teaching herd, and therefore staff members and the Swiss
National Horse Center were contacted to provide horses in active
training without a history of cough or perceived exercise intolerance
for inclusion in the study in addition to horses from the university
teaching herd. The different origin of horses also could have contrib-
uted some bias to the study.
Another limitation was the total number of cells counted for the
BALF cytology. The samples were evaluated by clinical pathologists of
the University of Zurich according to the standard clinical protocol,
which include the evaluation of 200 cells and not the 400 cells rec-
ommended in American College of Veterinary Internal Medicine
(ACVIM) consensus statements.1 This difference may have had an
impact on the classification of horses. However, the number of cells
counted for the BALF differential affected mostly mast cells, and to a
lesser extent neutrophils and eosinophils.12 The ACVIM consensus
statements indicate that up to 5% neutrophils in BALF cytology are
consistent with healthy controls, but that >10% indicate MEA.1
Including the 5% to 10% “gray zone” in the healthy group may have
biased our study, but forming more distinct groups was not possible
based on the number of horses.
A general limitation of EIT is that 1 plane of electrodes is used
and therefore only a lens-shape section of the lung is measured.
Recently, image reconstructions of a wider 3-dimensional part of the
equine thorax have been completed by using 2 EIT electrode
planes41 and may offer more extensive lung examinations in the
future.
Established lung function measurements were not performed for
comparison to EIT-measurements for practical reasons. In a previous
study, EIT changes were compared to plethysmography in healthy
horses during a histamine bronchoprovocation test and showed that
EIT and plethysmography flow variables had similar progression dur-
ing histamine challenge.15 Ours was an exploratory study to observe
if EIT can detect flow changes before and after exercise. In future
studies, the magnitude of EIT flow change should be compared to
changes evaluated using traditional measurement techniques of respi-
ratory mechanics.
4.6 | Conclusions
In conclusion, we showed that EIT measurements can be easily per-
formed in standing, nonsedated horses before and after exercise and
may provide a practical diagnostic tool for use in the field. More stud-
ies using larger cohorts and additional EIT-derived variables are
needed to further evaluate the diagnostic ability of EIT in horses
with EA.
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